Human SF20 (Stromal cell-derived growth factor SF20, C19orf10, MYDGF1, Myeloid-derived growth factor1 also formerly known as IL25) is a 15 kDa (predicted) bone marrow-derived monocyte and paracrine-acting protein that promotes cardiac myocyte survival and adaptive angiogenesis for cardiac protection and/or repair after myocardial infarction. SF20 stimulates endothelial cell proliferation through a MAPK1/3-, STAT3- and CCND1 mediated signaling pathway. It is thought to inhibit cardiac myocyte apoptosis in a PI3K/AKT-dependent signaling pathway and is involved in endothelial cell proliferation and angiogenesis. Human SF20 shares 87% aa identity with mouse SF20.
Human SF20/MYDGF Antibody
R&D Systems | Catalog # AF1147
Key Product Details
Species Reactivity
Validated:
Cited:
Applications
Validated:
Cited:
Label
Antibody Source
Product Specifications
Immunogen
Val32-Leu173
Accession # Q969H8
Specificity
Clonality
Host
Isotype
Scientific Data Images for Human SF20/MYDGF Antibody
Detection of Human SF20/MYDGF by Western Blot.
Western blot shows lysates of Jurkat human acute T cell leukemia cell line and HepG2 human hepatocellular carcinoma cell line. PVDF membrane was probed with 1 µg/mL of Goat Anti-Human SF20/MYDGF Antigen Affinity-purified Antibody (Catalog # AF1147) followed by HRP-conjugated Anti-Goat IgG Secondary Antibody (HAF017). A specific band was detected for SF20/MYDGF at approximately 15 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.
Detection of Human SF20/MYDGF by Simple WesternTM.
Simple Western lane view shows lysates of DU145 human prostate carcinoma cell line, loaded at 0.2 mg/mL. A specific band was detected for SF20/MYDGF at approximately 22 kDa (as indicated) using 25 µg/mL of Goat Anti-Human SF20/MYDGF Antigen Affinity-purified Polyclonal Antibody (Catalog # AF1147). This experiment was conducted under reducing conditions and using the 12-230 kDa separation system.Detection of SF20/MYDGF by Western Blot
rhMYDGF promotes HCAEC proliferation. HCAECs were stimulated with rhMYDGF (100 ng/mL unless otherwise indicated) in the absence or presence of PD98059 (PD, 20 µmol/L) or Static (1 nmol/L), as indicated. A, Representative immunoblots showing cyclin D1 and GAPDH expression in HCAECs. B, Representative immunoblots showing cyclin D1 and GAPDH expression in HCAECs stimulated for 12 h. C‐D, Western blot analysis was performed to examine the protein levels of cyclin D1. *P < .05, **P < .01 and ***P < .001 vs baseline (two independent‐sample t test) Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/31758636), licensed under a CC-BY license. Not internally tested by R&D Systems.Detection of SF20/MYDGF by Western Blot
rhMYDGF promotes HCAEC proliferation and is unstimulated or stimulated with rhMYDGF (100 ng/mL unless otherwise indicated), PD98059 (PD, 20 µmol/L) or Static (1 nmol/L), as indicated. A, Representative immunoblots showing phosphor (p)‐MAPK1/3 (Y204/T202), MAPK1/3, p‐STAT3 (S727) and p‐STAT3 (Y705) expression in HCAECs. B, Representative immunoblots showing p‐MAPK1/3, MAPK1/3, p‐STAT3 (S727) and p‐STAT3 (Y705) expression in HCAECs in the presence of MAPK1/3 inhibitor (PD98059). C, Representative immunoblots showing p‐MAPK1/3, MAPK1/3, p‐STAT3 (S727) and p‐STAT3 (Y705) expression in HCAECs in the presence of STAT3 inhibitor (Static). D‐F, Western blot analysis was performed to examine the protein levels of p‐MAPK1/3 and p‐STAT3 by ImageJ. *P < .05, **P < .01 and ***P < .001 vs baseline (two independent‐sample t test) Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/31758636), licensed under a CC-BY license. Not internally tested by R&D Systems.Detection of SF20/MYDGF by Western Blot
rhMYDGF promotes HCAEC proliferation and is unstimulated or stimulated with rhMYDGF (100 ng/mL unless otherwise indicated), PD98059 (PD, 20 µmol/L) or Static (1 nmol/L), as indicated. A, Representative immunoblots showing phosphor (p)‐MAPK1/3 (Y204/T202), MAPK1/3, p‐STAT3 (S727) and p‐STAT3 (Y705) expression in HCAECs. B, Representative immunoblots showing p‐MAPK1/3, MAPK1/3, p‐STAT3 (S727) and p‐STAT3 (Y705) expression in HCAECs in the presence of MAPK1/3 inhibitor (PD98059). C, Representative immunoblots showing p‐MAPK1/3, MAPK1/3, p‐STAT3 (S727) and p‐STAT3 (Y705) expression in HCAECs in the presence of STAT3 inhibitor (Static). D‐F, Western blot analysis was performed to examine the protein levels of p‐MAPK1/3 and p‐STAT3 by ImageJ. *P < .05, **P < .01 and ***P < .001 vs baseline (two independent‐sample t test) Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/31758636), licensed under a CC-BY license. Not internally tested by R&D Systems.Detection of SF20/MYDGF by Western Blot
rhMYDGF promotes HCAEC proliferation and is unstimulated or stimulated with rhMYDGF (100 ng/mL unless otherwise indicated), PD98059 (PD, 20 µmol/L) or Static (1 nmol/L), as indicated. A, Representative immunoblots showing phosphor (p)‐MAPK1/3 (Y204/T202), MAPK1/3, p‐STAT3 (S727) and p‐STAT3 (Y705) expression in HCAECs. B, Representative immunoblots showing p‐MAPK1/3, MAPK1/3, p‐STAT3 (S727) and p‐STAT3 (Y705) expression in HCAECs in the presence of MAPK1/3 inhibitor (PD98059). C, Representative immunoblots showing p‐MAPK1/3, MAPK1/3, p‐STAT3 (S727) and p‐STAT3 (Y705) expression in HCAECs in the presence of STAT3 inhibitor (Static). D‐F, Western blot analysis was performed to examine the protein levels of p‐MAPK1/3 and p‐STAT3 by ImageJ. *P < .05, **P < .01 and ***P < .001 vs baseline (two independent‐sample t test) Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/31758636), licensed under a CC-BY license. Not internally tested by R&D Systems.Applications for Human SF20/MYDGF Antibody
Simple Western
Sample: DU145 human prostate carcinoma cell line
Western Blot
Sample: Jurkat human acute T cell leukemia cell line and HepG2 human hepatocellular carcinoma cell line
Formulation, Preparation, and Storage
Purification
Reconstitution
Reconstitute at 0.2 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.
Formulation
Shipping
Stability & Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Calculators
Background: SF20/MYDGF
Long Name
Alternate Names
Gene Symbol
UniProt
Additional SF20/MYDGF Products
Product Documents for Human SF20/MYDGF Antibody
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Note: Certificate of Analysis not available for kit components.
Product Specific Notices for Human SF20/MYDGF Antibody
For research use only
Related Research Areas
Citations for Human SF20/MYDGF Antibody
Customer Reviews for Human SF20/MYDGF Antibody
There are currently no reviews for this product. Be the first to review Human SF20/MYDGF Antibody and earn rewards!
Have you used Human SF20/MYDGF Antibody?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
Protocols
Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.
- Cellular Response to Hypoxia Protocols
- R&D Systems Quality Control Western Blot Protocol
- Troubleshooting Guide: Western Blot Figures
- Western Blot Conditions
- Western Blot Protocol
- Western Blot Protocol for Cell Lysates
- Western Blot Troubleshooting
- Western Blot Troubleshooting Guide
- View all Protocols, Troubleshooting, Illustrated assays and Webinars